OncoTargets and Therapy
Volume 13, 2020 - Issue
Open access
53
Views
5
CrossRef citations to date
0
Altmetric
Original Research
Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways
Hongchao Zhen1 Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing100050, People’s Republic of China
, Guangxin Li2 Radiation Oncology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing102218, People’s Republic of China
, Pengfei Zhao1 Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing100050, People’s Republic of China
, Ying Zhang1 Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing100050, People’s Republic of China
, Jing Wang1 Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing100050, People’s Republic of China
, Junxian Yu3 Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing100050, People’s Republic of China
& Bangwei Cao1 Cancer Center, Beijing Friendship Hospital, Capital Medical University, Beijing100050, People’s Republic of ChinaCorrespondence[email protected]
show all
Pages 12325-12339
|
Published online: 01 Dec 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.